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ABSTRACT  
Purpose: To evaluate the correlation between endorectal 
ultrasound (ERUS) and magnetic resonance imaging (MRI) 
in preoperative staging of rectal cancer. 
Materials and Methods: Fifty patients with rectal cancer 
underwent ERUS and 3-Tesla MRI for preoperative staging. 
With both imaging techniques were evaluated the following 
features: lesion site, tumour longitudinal extent, distance 
between lesion distal margins and puborectalis muscle, 
levator ani muscles infiltration, depth of extramural spread, 
mesorectal lymph nodes involvement and pelvic organs 
infiltration. 
MRI evaluated also the following features: maximum 
thickness of the lesion, distance between externa margins of 
the lesion and mesorectal fascia and overcoming of the 
peritoneal reflection. All MR studies were evaluated by two 
experienced professionals board certified in radiology and 
experts in gastrointestinal imaging. 
The correlation between MRI and ultrasound data was 
calculated for each measure using the Spearman rank test (p-
values <0.05 were considered statistically significant). 
The interobserver agreement for MRI was assessed by using 
the Cohen’s kappa statistics. 
Eleven patients underwent directly to surgical resection 
without neoadjuvant therapy, and the surgical specimen was 
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used as standard of reference for determination of depth of 
invasion (T stage) and perirectal nodal involvement (N 
stage). 
Results: ERUS and MRI showed a statistically significant 
correlation for the lesion site (MRI observer A vs ERUS: 
rs=0.873, p<0.000001/ MRI observer B vs ERUS: rs=0.8485, 
p<0.000001), the tumour longitudinal extent (MRI observer 
A vs ERUS: rs=0.378, p=0.010393/ MRI observer B vs 
ERUS: rs=0.3794, p=0.010131), the distance between lesion 
and puborectalis muscle (MRI observer A vs ERUS: 
rs=0.7954, p<0.000001/ MRI observer B vs ERUS: 
rs=0.7989, p<0.000001) and the depth of extramural spread 
(MRI observer A vs ERUS: rs=0.5107, p=0.000149/ MRI 
observer B vs ERUS: rs=0.5046, p=0.000186).  
Moreover, TRUS and MRI were able to demonstrate the 
levator ani muscles infiltration with an overall agreement of 
82% for MRI reader A and 80% for MRI reader B, the lymph 
nodes involvement with an agreement of 68% for MRI reader 
A and 76% for MRI reader B and the pelvic organs 
infiltration with an agreement of 80% for both MRI reader. 
MRI allowed, however, the evaluation of other staging 
parameters, as the distance between lesion and mesorectal 
fascia. 
The interobserver agreement between MRI reader A and B 
was 0.91 for the lesion site, 0.914 for the distance between 
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lesion and puborectalis muscle, 0.791 for the tumour 
longitudinal extent, 0.758 for the depth of extramural spread, 
0.734 for the maximum thickness of the lesion and 0.48 for 
the distance between lesion and mesorectal fascia. 
There was also an agreement between the two observers of 
100% for the pelvic organs involvement, of 96% for the 
overcoming of the anterior peritoneal reflection, of 88% for 
the mesorectal lymph nodes involvement and of 82% for the 
levator ani muscles infiltration. 
Conclusions: The good agreement between MRI and TRUS 
in preoperative staging of rectal cancer argues in favor of the 
use of MRI, because it also allows a more comprehensive 
local assessment. 
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INTRODUCTION 
Colorectal cancer is an important public health problem: 
there are nearly one million new cases of colorectal cancer 
diagnosed world-wide each year and it is the third leading 
cause of death with over half a million deaths [1,2]. 
In particularly, rectal cancer, defined as a tumor with its 
lower edge within 15 cm from the anal verge, account for 
about a third of all colorectal malignancies [3]. 
In the last decades, we have seen dramatic improvements in 
the outcomes of patients with rectal cancer. The rate of local 
recurrence has decreased, the probability of survival has 
increased, and the quality of life has improved. Advances in 
surgical pathology, refinements in surgical techniques, and 
the widespread use of preoperative chemo-radiotherapy 
(CRT), have all contributed to these improvements. 
Advances in imaging have also played a pivotal role in 
identifying the rectal tumors at risk for recurrence, helping in 
planning surgical procedures and selecting patients for 
neoadjuvant therapy [4]. 
 
RECTAL ANATOMY 
The rectum varies in lenght from 10 to 15 cm, from the upper 
end of anal canal to the recto-sigmoid junction, and can be 
divided into three segments from the anal verge: lower 
rectum, middle rectum, and upper rectum. The rectal wall is 
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composed of three layers: mucosa, submucosa and 
muscularis layer, that are best visualized on ERUS. 
The rectum is surrounded by mesorectal fat (mesorectum) 
containing lymph nodes, superior hemorrhoidal vessels and 
fibrous tissue, and it is bordered by a thin membrane called 
mesorectal fascia [2]. 
The mesorectum is thick posteriorly but either almost absent 
anteriorly where it is separated from the urogenital organs by 
the Denonvillier’s fascia.  
Distally the rectum is in direct contact with the levator ani 
muscles, and this relationship must be taken into 
consideration when deciding between an abdominoperitoneal 
excision or a sphincter-sparing procedure for rectal cancers 
located at or below the level of the anorectal ring [4]. 
 
LOCAL STAGING OF RECTAL CANCER 
The diagnosis is usually established by means of clinical 
examination (rectal digital examination), endoscopy 
(sigmoidoscopy and colonoscopy), double-contrast enema 
examination, and histologic confirmation, supplemented by 
biochemistry (eg, blood carcinoembryonic antigen 
measurement).  
Unfortunately, all these techniques are poor indicators of the 
depth of invasion (T stage) and lymph node involvement (N 
stage), which are both important features for prognosis [5]. 
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Computed Tomography (CT) 
CT is used for pre-operative assessment of distant metastases, 
but don’t have a role in local staging because it does not 
distinguish rectal wall layers, however it can evaluate lymph 
nodes (mesorectal but also iliac and mesenteric or 
retroperitoneal) [6]. 
 
Endorectal Ultrasonography (ERUS) 
ERUS has the advantage to visualize all layers of the rectal 
wall and can demonstrate other anatomical structures, such as 
seminal vescicles, prostate, cervix, vagina, blood vessels and 
perirectal nodes situated into the field of view of the probe, 
also the puborectalis muscle and the anal sphincters are 
clearly visualized on ERUS [4]. 
On ERUS imaging, the rectal wall is visualized according to 
the Beynon five-layers model described below: 
• first hyperechoic layer - interface between the balloon 
and its contained water and the mucosal surface; 
• second hypoechoic layer - mucosa and muscolaris 
mucosae; 
• third hyperechoic layer – submucosa; 
• fourth hypoechoic layer – muscularis propria;  
• fifth hyperechoic layer – interface between the 
muscularis propria and perirectal fat or serosa if present 
[7] (Fig.1). 
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Rectal tumors appear as expansions of the first hypoechoic 
layer of the rectal wall, distorting and interrupting the other 
layers of the rectal wall from the inside out. 
An ultrasound T classification, similar to the T classification 
of the AJCC TNM staging system is based on tumor 
disruption of the different echographic layers.  
Metastatic lymph nodes appear as hypoechoic deposits, with 
an echogenicity similar to that of the primary tumor. 
ERUS is a very accurate tool for measuring size, 
circumference and distance of the tumor from various 
anatomic landmarks (eg, sphincters, prostate, etc), and it can 
delineate the relationship of distal rectal cancer with internal 
and external anal sphincters [4]. 
 
Magnetic Resonance Imaging (MRI) 
The introduction of phased-array coils and the use of T2-
weighted fast spin echo thin-section sequences have enabled 
accurate determination of prognostic factors and anatomic 
assessment of the pelvis by delineating rectal tumors through 
increases in spatial and contrast resolution. 
MRI can accurately predict the depth of extramural 
penetration, and more importantly, predict the relationship 
between tumor and mesorectal fascia, which is an important 
risk factor for local recurrence. 
T2-weighted images are the most suitable for depicting the 
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rectal wall anatomy, and MRI can distinguish: 
• inner hyperintense layer – mucosa and submucosa (no 
differention is possible between these two components); 
• intermediate hypointense layer – muscularis propria; 
• outer hyperintense layer – perirectal fat tissue. 
The mesorectal fascia can be identified as a thin, low-signal-
intensity structure that envelops the mesorectum and the 
surrounding perirectal fat (Fig.2). 
The anal canal can be easily visualized in MRI of the lower 
rectum with clear depiction of the levator ani muscle, the 
puborectalis muscle, and the internal and external anal 
sphincters [8]. 
On T2-weighted images, the tumour appears as epithelial-
based thickening with a signal intensity slightly higher than 
the muscularis propria [6]. 
Metastatic lymph nodes appear as hypointense deposits into 
the mesorectal fat, and the use of border contour and signal 
intensity characteristics in addition to size criteria can 
improve the accuracy of nodal staging [9]. 
Rectal MRI with phased-array coil provides a full evaluation 
of the rectal wall layers, mesorectal fat and fascia and it 
improves patient comfort compared with the use of an 
endorectal coil or ERUS. Moreover, stenosing lesions and 
tumors at the rectosigmoid junction can be evaluated in all 
cases by MRI. 
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TNM STAGING  
The more recent clinical staging classification from the 
American Joint Committee on Cancer (2010) takes into 
account the subclassification of T3 tumors (Tab.1). 
Moreover, we can distinguish between “T3 early” if tumor 
extends ≤5 mm beyond muscularis propria and “T3 
advanced” if tumor extends >5 mm. 
 
SURGICAL TREATMENT 
At the present total mesorecal excision (TME) is the surgical 
approach of choice for rectal cancer, because is able to 
reduce the local recurrence rate to less than 10% [10], 
improving the 5-year survival rate if compared with 
conventional surgery.  
TME is achieved by means of a dissection along the plane 
that separates the visceral from the parietal layers of the 
perirectal pelvic fascia, thus allowing radical removal of the 
rectum and its surrounding mesorectum [11]. 
The circumferential resection margin (CRM) is the lateral or 
radial resection margin created by the surgeon and the ideal 
plane of resection is just outside the mesorectal fascia. 
 
RISK FACTOR FOR LOCAL RECURRENCE 
In large databases, the risk factors associated with local 
recurrence are generally similar to the risk factors for distant 
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recurrence: T stage, N stage, distance to the CRM, perineural 
invasion, lymph node and blood vessel invasion, and 
histologic grade. Of these risk factors, the T and N stage are 
commonly used for (neo) adjuvant treatment decisions,  and 
recently also the distance to the CRM [12]. 
Incomplete removal of the lateral spread of the tumour is now 
generally accepted as the reason for most of local recurrences 
that may be reduced thanks to perioperative radiotherapy.  
In Europe there is a preference for preoperative radiotherapy, 
based on the results of several trials, among which the most 
important is the Swedish Rectal Cancer Trial that showed the 
most convincing results, with a local recurrence rate of 11% 
after radiotherapy compared with a rate of 27% in the 
controls, and improved survival [13]. 
Attention has also been directed at the surgical technique 
itself as a determinant of local recurrence rates. Histology of 
resection specimens has shown that the frequency of local 
recurrence greatly decreases when a tumour-free 
circumferential resection margin of more than 1 mm can be 
obtained [14]. 
 
Tumor stage 
Transrectal ultrasound (TRUS) is very accurate for staging of 
superficial rectal tumors but is not as useful for staging of 
	   13	  
advanced rectal cancers, so it is the gold standard for 
discriminating stage T1 from T2 [2]. 
Instead MRI is very accurate for identifying large T3 and T4 
tumors and invasion of mesorectal fascia [5]. 
Most staging failures with MRI occur in the differentiation 
between T1 and T2 lesions and between T2 and borderline 
T3 lesions [12]. 
 
Nodal stage 
Nodal disease is one of the most important risk factors for 
both local and distant recurrence, but identifying nodal 
involvement with imaging remains difficult because size 
criteria used on its own result inaccurate. In addition to size 
with 5 mm as a cut-off, roundness, border irregularity and 
hypoehoic nature (ERUS)/ heterogeneus signal (MRI) can 
provide additional accuracy. 
 
Circumferential Resection Margin (CRM) 
The association of CRM with local recurrence was first 
demostrated in 1986 by Professor Quirke’s group [15] and 
some trials have demonstrated that patients with CRM 
involvement have 3.5 times the risk of local recurrence and 
double the risk of death [16]. 
The CRM is identified with the mesorectal fascia and a 
positive CRM is defined as a closed distance of 1 mm or less 
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between tumor and resection margin and, it can be the result 
of an inadequate total mesorectal excision (TME) surgery or 
an advanced tumor that comes close to or invades the 
mesorectal fascia. 
The mesorectal fascia is very difficult to identify with ERUS, 
except when there is an invasion of vagina, prostate, or 
seminal vesicles, instead many single center studies have 
shown that MRI is highly accurate for the prediction of an 
involved CRM [12,14]. 
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MATERIALS AND METHODS 
Patients 
From May 2011 to May 2013, fifty patients with biopsy 
proved rectal cancer were submitted to MRI and ERUS. All 
patients underwent colonoscopic examination in which a 
bioptic procedure was performed. 
The inclusion criteria were (1) histologically confirmed rectal 
adenocarcinoma and (2) distal end of tumor located within 15 
cm from the anal verge. 
The study consisted of 32 (64%) men and 18 (36%) women 
with a mean age of 68.3 years (range 34-87 years). 
Thirty-nine patients (78%) underwent to preoperative 
chemoradiotherapy (CRT) followed by surgical treatment, 
instead eleven patients (22%) underwent immediately to 
surgical treatment (TME) without CRT. 
Following surgery, operative specimens were analysed by a 
pathologist. 
 
MRI technique and parameters 
All MRI examinations were performed with a 3-Tesla 
scanner (Discovery 750, General Electric, Milwaukee, 
Wisconsin, USA) using a pelvic phased-array surface coil 
(8US TORSOPA).  
The night before the MR study, the patients were given a 
water enema to clean the rectum, and the examinations were 
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performed after luminal distension with rectal gel in a 
variable quantity from 60 to 120 mL relating to the location 
of the lesion. It is important not to overdistend the rectum 
with rectal gel since this could distort the anatomy and reduce 
the ability to interrogate the surrounding mesorectum, which 
would be compressed by overdistension. 
The patient is positioned supine, and the phased-array surface 
coil is placed on the pelvis in such a way that the lower edge 
of the coil lies below the pubic bone.  
The following sequences were acquired: 
- axial T2-weighted Fast Spin Echo (FSE) (repetition 
time [TR]/ echo time [TE] 3500-6000/ 90-150 ms), 
field of view 24 cm, section thickness 5 mm, interval 
0.5 mm, matrix 384x224; 
- sagittal T2-weighted Fast Spin Echo (FSE) (repetition 
time [TR]/ echo time [TE] 3500-6000/ 90-150 ms), 
field of view 24 cm, section thickness 5 mm, interval 
0.5 mm, matrix 384x224; 
- coronal T2-weighted Fast Spin Echo (FSE) (repetition 
time [TR]/ echo time [TE] 3500-6000/ 90-150 ms), 
field of view 24 cm, section thickness 5 mm, interval 
0.5 mm, matrix 384x224; 
- oblique-axial T2-weighted Fast Spin Echo (FSE) 
(repetition time [TR]/ echo time [TE] 3500-6000/ 90-
150 ms) on a plane perpendicular to the long axis of the 
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tumor as visualized in the sagittal sequences, field of 
view 22 cm, section thickness 3 mm, interval 0.2 mm, 
matrix 384x224; 
- sagittal 3D T2-weighted Fast Spin Echo (CUBE) 
(repetition time [TR]/ echo time [TE] 1600/ 85-95 ms), 
field of view 24 cm, section thickness 0.9 mm, no 
interspace, matrix 288x256; 
- axial diffusion-weighted (DWI) (repetition time [TR]/ 
echo time [TE] 2000-6000/ 50-55 ms), field of view 30-
32 cm, section thickness 5-6 mm; interval 1-1.2 mm; b-
value 0-500-800 sec/mm2. 
No contrast enhancement was used and the overall 
acquisition time varied between 20 and 30 minutes. 
 
MR images analysis  
All MR examinations were interpreted by two experienced 
gastrointestinal radiologists blinded to each other and to the 
endosonographic findings. 
The following features were described: 
- lesion site (distance from the anal verge); 
- tumour longitudinal extent; 
- maximum thickness of the lesion; 
- distance between lesion and puborectalis muscle; 
- levator ani muscles infiltration;  
- depth of extramural spread; 
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- distance between lesion and mesorectal fascia; 
- overcoming of the anterior peritoneal reflection; 
- mesorectal, iliac and obturatory lymph node 
involvement; 
- pelvic organs infiltration. 
Local MR staging was established according to the TNM 
system.  
Positive (N1-N2) lymph nodes were considered if greater 
than 5mm in diameter, with an irregular border and mixed-
signal intensity. 
The mesorectal fascia was demostated as a low-intensity fine 
structure enveloping the mesorectum.  
 
ERUS technique and parameters 
ERUS was performed by an experienced operator, using a 
Pro Focus BK Medical ultrasound machine with a rigid 
rotating probe (Type 2050) and a 6/16 MHz transducer (BK 
Medical, Wilmington, Massachusetts, USA) that provided a 
360° radial scan of the rectal wall and surrounding structures.  
All patients received an enema to clean the rectum the night 
before the examination. 
The procedure was performed with patients in the left lateral 
decubitus position without sedation. A digital rectal and 
proctoscopic examination was performed to assess the 
distance from the anal verge and the longitudinal extent. The 
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proctoscope permitted the passage of the ultrasound probe to 
facilitate positioning of the probe above the lesion; this 
facilitated complete imaging of the lesion from its most 
proximal to distal extend as well the proximal mesorectum, 
which may harbor involved lymph nodes. 
The transducer rotated inside the head of the probe to provide 
a 360° field of view and the advantage of 3D ERUS was that 
the volume could be freely rotated, rendered, tilted and 
sliced, providing the operator with an infinite variety of 
section parameters, as well as visualization of the lesion at 
different angles and in different planes (coronal, frontal, 
axial). Multiplanar reformatting was probably the most useful 
way to demonstate the adjacent structures in several planes. 	  
ERUS images analysis  
All ERUS examinations were performed by a single operator, 
who evaluated  the following features: 
- lesion site (distance from the anal verge); 
- tumour longitudinal extent; 
- distance between lesion and puborectalis muscle; 
- levator ani muscles (puborectalis muscle) infiltration;  
- depth of extramural spread; 
- mesorectal lymph node involvement; 
- pelvic organs infiltration. 
On ERUS imaging, rectal tumors appear as expansions of the 
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first hypoechoic layer of the rectal wall, distorting and 
interrupting the other layers of the rectal wall from the inside 
out. 
The sonographic criteria for identifying involved lymph 
nodes consist in size greater than 5mm, mixed signal 
intensity, irregular margins and spherical rather than ovoid or 
flat shape. 
 
Standard of reference 
For patients who proceeded directly to surgical resection 
without neoadjuvant therapy (n=11), the surgical resection 
specimen was used as standard of reference for determination 
of depth of invasion (T stage) and perirectal nodal status (N 
stage). 
Pathological examination was done without knowledge of the 
results of ERUS and MRI, and the surgical specimen was 
staged (TNM) according to the guidelines of the American 
Joint Commitee on Cancer (AJCC). 
 
Statistical analysis 
The correlation between MRI and ultrasound data was 
calculated for each parameter using two-tailed Spearmanʼs 
rank-order correlation coefficient and a p-value of less than 
0.05 was considered statistically significant. 
The interobserver agreement for MR imaging was assessed 
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by using the Cohen’s kappa statistics. Kappa values were 
interpreted in the following way: absence of agreement 0, 
slight agreement 0.20, fair agreement 0.21-0.40, moderate 
agreement 0.41-0.60, substantial agreement 0.61-0.8, and 
almost perfect agreement 0.81-1 as proposed by Landis et al. 
[17]. Confidence limits were set at 95 percent. 
Descriptive statistics were also used. 
All calculations were done by using SPSS statistical software 
(SPSS Inc, Chicago, Ill, USA). 
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RESULTS 
From May 2011 to May 2013, fifty patients (39 treated with 
neoadjuvant chemoradiotherapy followed by surgery and 11 
with surgical resection alone) were evaluated with MRI and 
ERUS. 
Characteristics of the patients and tumors are described in 
Table 2. 
Thirty-two patients (64%) were men and 18 (36%) women 
with a mean age of 68.3±12.2 years (range, 34-87 years).  
The mean distance of the tumor from the anal verge was 
8.26±2.87 cm (range, 2-14 cm); ten cancers (20%) were in 
the lower third of the rectum, twenty-nine cancers (58%) 
were in the middle third of the rectum and eleven cancers 
(22%) were in the upper third of the rectum. Forty-two 
tumors (84%) were below the peritoneal reflection. 
The pathological T stage of the eleven patients who 
underwent to surgical resection alone was: pT2 in 4 patients, 
pT3 in 6 patients and pT4 in 1 patient and, lymph nodes were 
involved by the tumor in 8 patients. 
Patient acceptance of ERUS and MRI was good in all cases, 
and there were no complications. 
 
Correlation between TRUS and MRI 
TRUS data and MRI data of reader A, showed a statistically 
significant correlation for the lesion site (rs=0.873, 
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p<0.000001), the tumour longitudinal extent (rs=0.378, 
p=0.010393), the distance between lesion and puborectalis 
muscle (rs=0.7954, p<0.000001) and the depth of extramural 
spread (rs=0.5107, p=0.000149). 
Also, TRUS data and MRI data of reader B revealed a 
statistically significant correlation for the lesion site 
(rs=0.8485, p<0.000001), the tumour longitudinal extent 
(rs=0.3794, p=0.010131), the distance between lesion and 
puborectalis muscle (rs=0.7989, p<0.000001) and the depth 
of extramural spread (rs=0.5046, p=0.000186). 
Moreover, TRUS and MRI were able to demonstrate the 
levator ani muscles infiltration with an overall agreement of 
82% for MRI reader A and 80% for MRI reader B, the lymph 
node involvement with an agreement of 68% for MRI reader 
A and 76% for MRI reader B and the pelvic organs 
infiltration with an agreement of 80% for both MRI readers. 
Correlation between TRUS and MRI are scheduled on Table 
3. 
 
MRI interobserver agreement 
The interobserver agreement between MRI readers A and B 
was almost perfect for the lesion site (k=0,91; 95% CI: 
0,882-0,937) and the distance between lesion and 
puborectalis muscle (k= 0,914; 95% CI: 0,878-0,950), there 
was a substantial agreement for the tumour longitudinal 
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extent (k= 0,791; 95% CI: 0,700-0,882), the depth of 
extramural spread (k= 0,758; 95% CI: 0,672-0,844) and the 
maximum thickness of the lesion (k= 0,734; 95% CI: 0,625-
0,844), instead there was only a moderate agreement for the 
distance between lesion and mesorectal fascia (k= 0,48; 95% 
CI: 0,312-0,649). 
There was also an agreement between the two observers of 
100% for the pelvic organs involvement, of 96% for the 
overcoming of the anterior peritoneal reflection, of 88% for 
the mesorectal lymph nodes involvement and of 82% for the 
levator ani muscles infiltration. 
 
Distance between tumor and mesorectal fascia 
The relationship between tumor and mesorectal fascia is an 
important risk factor for local recurrence, but its involvement 
can correctly visualized only on MRI. 
In our study the mesorectal fascia was visualized on MRI in 
all patients. 
For MRI observer A the mean distance between lesion and 
mesorectal fascia was 0.74 cm (range, 0-2.2 cm), and for 
observer B it was 0.59 cm (range, 0-1.8 cm). 
The distance between lesion and mesorectal fascia was <5 
mm in seventeen patients (34%) for MRI reader A and in 
twenty-two patients (44%) for MRI reader B with a moderate 
interobserver agreement. 
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Agreement between MRI/ERUS and histologic examination 
Eleven patients underwent to surgical resection alone and the 
agreement between MRI and histologic examination (HE) 
was 45.5% for T stage and 63.6% for N stage, instead the 
agreement between ERUS and histologic examination was 
27.3% for T stage and 63.6% for N stage. 
T stage was overestimated in 7 cases (63.6%) with TRUS and 
in 6 cases (54.5%) with MRI, and it was underestimed in 1 
cases (9.1%) with TRUS and in any case with MRI (Tab. 
4,5). 
N stage was overestimated in 3 cases (27.3%) with TRUS 
and MRI, and it was underestimed in 1 cases (9.1%) with 
TRUS and MRI. 
Overstaging and understaging of MRI and ERUS in term of 
predicting T and N stage are summarized in Table 6. 
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DISCUSSION 
The correct staging of rectal cancer is of high relevance since 
the treatment options depend on the stage at presentation. The 
common practice (on the basis of oncologic guidelines) is to 
administer neoadjuvant therapy followed by surgery to 
patients with T3 and T4 tumors or any tumor with positive 
locoregional lymph nodes, instead patients with T2 tumors 
are treated with surgical resection (TME) and T1 tumors may 
be correctly resected either by endoscopic techniques 
(mucosectomy) or minimally invasive surgical procedures 
(transanal endoscopic microsurgery). 
Although rectal tumors can be diagnosed using digital 
examination, barium enema, and colonoscopy/ 
sigmoidoscopy, these endoluminal techniques do not provide 
sufficient information about the extraluminal spread of the 
tumor for preoperative planning. Therefore CT, ERUS and 
MRI are the imaging modalities predominantly utilized in the 
preoperative staging of rectal cancer.  
CT is unable to differentiate the different layers of the rectal 
wall and has lower overall predictive accuracy than ERUS 
and MRI in locoregional staging, however it is used to search 
for distant metastasis (e.g. lung, liver). 
Bipat et al. [5] published an extensive meta-analysis in 2004 
comparing ERUS, CT and MRI, including a variety of MR 
techniques and coils, they found that ERUS was the best 
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technique for assessing local invasion, with a sensitivity and 
specificity of detecting muscularis propria invasion of 94% 
and 69% for MRI and, 94% and 86% for ERUS and a 
sensitivity and specificity of detecting perirectal tissue 
invasion of 82% and 76% for MRI and, 90% and 75% for 
ERUS. 
Later, in 2013, Beaumont et al. [18] compiled the results of 
several large studies (n=40 or greater) suggested that ERUS 
was significantly more sensitive than MRI for the assessment 
of T1 and T2 tumors, with no significant difference between 
the two modalities in the staging of T3 and T4 tumors. 
In fact it has been demonstrated that the most staging failures 
with MRI occur in the differentiation between T1 and T2 
lesions and between T2 and “T3 early” lesions. A T1 tumor 
cannot be reliably distinguished from T2 because the 
submucosal layer is generally not visualized on phased-array 
MRI and the difficulty in determining T2 from “T3 early” 
lesions is often caused by the presence of desmoplastic 
reaction within the peritumoral tissues that made difficult the 
MR differentiation between perirectal fat spiculation, caused 
by fibrosis alone from those containing tumour cells. ERUS 
has the same difficulty in distinguishing T2 from “T3 early”, 
and this often involves an overstaging [14]. 
In our study,	   considering only the eleven patients who 
underwent surgery without CRT, T stage was overestimated 
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in 7 cases (63.6%) with ERUS and in 6 cases (54.5%) with 
MRI, in particularly ERUS has not been able to distinguish 
T2 from T3 in 3 cases (42.9%) and MRI in 2 cases (33.3%). 
Distinguish between T2 from T3 tumors at the immediate 
interface between the muscle coat and the extramural fat is of 
little importance in preoperative clinical decision making 
because the outcome of patients with “early T3” tumors is 
good with surgery alone [11], instead is important evaluate 
the depth of extramural spread in tumors that are clearly T3, 
whether or not the tumour threatens the mesorectal fascia, 
and whether the tumour has any other markers of 
aggressiveness, such as nodal metastases, vascular invasion 
or local peritoneal involvement, because they are important 
in determining prognosis and stratifying patients for 
preoperative therapy [19]. 
In fact, tumors with 5 mm or less of extramural spread 
regardless of lymph node status have an 85% 5 year cancer-
specific survival rate compared with poorer prognosis of 
tumors with more than 5 mm spread, which have only a 54% 
5 year cancer-specific survival rate [20]. 
Unfortunately our study did not demonstrate an high 
accuracy of preoperative MRI or ERUS in the prediction of 
correct T stage, since the agreement with histopathology was 
about 45.5% for MRI and only 27.3 for ERUS and it did not 
correlate with the data reported in the most of the studies 
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published in literature (65%-100%) [21]. 
The single most important element in the realization of local 
control is a free circumferential resection margin (CRM) and 
Quirke et al. [15] already in 1986 demonstrated that 
microscopically inadequate radial margins lead to a 
recurrence rate of 86% and many subsequent studies have 
confirmed the importance of a free CRM. 
It has been suggested that circumferential resection margin 
status is even more informative in treatment planning than T 
stage, so the currently TNM classification, based on depth of 
bowel infiltration, does not distinguish between primary 
resectable tumors and locally advanced tumors infact a T3 
tumor can be either primary resectable with a wide tumor-
free CRM or locally advanced with a close or involved CRM 
[22]. 
For the prediction of the CRM, the radiologists assessed the 
MRI scans for the shortest distance from the outermost part 
of the tumour to the adjacent mesorectal fascia [14], so 
positive margins can be due to main tumor extension, tumor 
deposits, extramural vascular invasion, or suspicious lymph 
nodes. [23]. 
Beets-Tan et al. [14] in a study of preoperative MRI in 76 
patients, concluded that a tumour-free zone of 1 mm by 
histology could be predicted with a high degree of certainty 
when the measured distance on MRI was at least 5 mm, and a 
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histological margin of at least 2 mm when the MRI distance 
was at least 6 mm. 
Histology of resection specimens has shown that the 
frequency of local recurrence greatly decreas when a tumor- 
free CRM of more than 1 mm can be obtained. 
With ERUS it is very difficult to identify the mesorectal 
fascia in patients with a “threatened CRM,” except when it 
shows invasion of vagina, prostate, or seminal vesicles. Many 
single-center studies have shown that MRI is highly accurate 
for the prediction of an involved CRM [14]. 
Lymph nodes assessment remains an unresolved problem in 
the preoperative staging of rectal cancer for both ERUS and 
MRI. 
In the meta-analysis of Bipat et al. [5], the sensitivity and 
specificity of detecting lymph node involvement was 66% 
and 76% for MRI and, 67% and 78% for ERUS.  
Although short axis diameter greater than 5 mm was the 
criterion most commonly used to predict lymph node 
metastases on MRI, our review found little evidence to 
support this particular cut-off and Brown et al. [9] suggested 
that the use of border contour and signal intensity 
characteristics, in addition to size criteria, can improve the 
accuracy of nodal staging.  
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Our study, considering only the 11 patients who underwent 
surgery without CRT, addresses an overall agreement for 
lymph nodes involvement of 63.6% for ERUS and MRI.  
Due to its wide field of view, MRI can also predict the 
peritoneal involvement, that represents an independent risk 
factor for intraperitoneal recurrence after surgery.  
Moreover, the identification of the peritoneal attachment and 
its involvement is important because tumors with peritoneal 
reflection invasion (T4a) are treated as colon cancers and 
these tumors should be reported at MR imaging as 
circumferential resection margin (CRM) negative because 
CRM corresponds to the cut of surgical resection margin and 
does not cover the anterior aspect of the upper rectum 
[23,24]. 
In our study, ERUS and MRI have a statistically significant 
correlation for the assessment of lesion site, tumour 
longitudinal extent, distance between lesion and puborectalis 
muscle, depth of extramural spread, and an overall good 
agreement for the levator ani muscles infiltration, the 
mesorectal lymph nodes involvement and the pelvic organs 
infiltration. 
MRI also allowed to evaluate the maximum thickness of the 
lesion, the distance between lesion and mesorectal fascia, the 
overcoming of the anterior peritoneal reflection and the iliac 
and obturatory lymph nodes involvement. 
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Although, ERUS can distinguish tumor T1 stage from T2 
because it shows all the different layers of the rectal wall, it is 
operator dependent and requires a learning curve for correct 
staging of rectal cancer.  
Moreover, the accuracy of ERUS in the staging of rectal 
cancer has been highly variable, with values ranging 
anywhere from 69%-89% and the study of Harewood et al. 
[25] on the potential biases have showed an inverse 
relationship between study size and reported ERUS accuracy, 
as well as higher reported accuracy values in older studies 
and  this study also noted that most published studies utilized 
very experienced operators, so actual accuracy of ERUS is 
probably much lower in common practice than in publication. 
ERUS can not assess stenotic tumors or lesions located in the 
upper rectum and it can not visualize mesorectal fascia and 
tumor extension into surrounding organs because of the 
limited field of view. 
Endorectal MRI has the same limitations of ERUS and it has 
been almost completely replaced by phased-array coils that 
have made better spatial resolution with improved signal-to-
noise ratio, without the limitations of endorectal MRI and 
they have the advantage of having a larger field of view of 
the mesorectal fascia [26]. 
Downsides of MRI remain the limited availability, the high 
cost, the need to obtain good standard high-resolution 
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sequences and the interpretation of the images that depends 
on the knowledge and expertise of the radiologist [27]. 
With routinary use of MRI, approximately 40-50% of 
patients can be treated successfully with primary surgery 
without significant risk of local recurrence or systemic 
failure. For the remaining patients, the use of preoperative-
CRT is aimed at reducing the size of the primary tumour and 
making irresectable tumour resectable with tumour free 
circumferential margins to reduce the risk of recurrence [24].  
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CONCLUSIONS 
With the development of the technique (faster acquisitions, 
dedicated external coils, contrast agents, etc.), MRI has 
achieved almost the same accuracy as ERUS for local staging 
of rectal cancer.  
In this study comparing those two modalities we can state 
that phased-array MRI is slightly superior in determining the 
depth of transmural tumor invasion (T stage) and it has the 
same value in detecting lymph node metastasis (N stage) as 
compared to ERUS. 
MRI has also an additional value in the preoperative 
evaluation of other markers of tumour aggression such as 
iliac and obturatory nodal involvement, overcoming of the 
peritoneal reflection, and especially the involvement of the 
mesorectal fascia, which represents the CRM.  
In conclusion, there was a very good intermodality agreement 
between TRUS and MRI and because the extramural spread 
is the most important prognostic indicator with regard to T 
stage, we suggest the routinary use of MRI for the staging of 
rectal cancer with the use of ERUS only in preoperative 
staging of patients with early tumors (T1-T2) who can be 
avoided from unnecessary TME. 
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Table 1: TNM staging of rectal cancer. 
 T staging 
T1 Tumor invades mucosa and submucosa 
T2 Tumor invades but does not penetrate muscularis propria 
T3 Tumor invades subserosa through muscularis propria 
T3a: tumor extends <1 mm beyond muscularis propria 
T3b: tumor extends ≥1-5 mm beyond muscularis propria 
T3c: tumor extends >5-15 mm beyond muscularis propria 
T3d: tumor extends ≥15 mm beyond muscularis propria 
T4 Tumor invades peritoneal reflection (T4a) or other organs (T4b) 
 N staging 
N0 No metastatic lymph nodes 
N1 Metastasis in 1-3 perirectal nodes 
N2 Metastasis in 4 or more perirectal nodes 
 M staging 
M0 No distant metastasis 
M1 Distant metastasis 
 
 
Table 2: Characteristics of the patients and tumors. 
Variable N 
Age  68.3±12.2 years (range, 34-87) 
Gender 
• male 
• female 
 
• 32 (64%) 
• 18 (36%) 
Distance from anal verge 8.26±2.87 cm (range, 2-14) 
Location  
• upper third of the rectum 
• middle third of the rectum 
• lower third of the rectum 
 
• 11 (22%) 
• 29 (58%) 
• 10 (20%) 
Location in relation to peritoneal 
reflection 
• below 
• above 
 
• 42 (84%) 
• 8 (16%) 
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Table 3: Correlation between TRUS and MRI. 
 TRUS–MRI reader A TRUS–MRI reader B 
Lesion site 
 
rs=0.873 
p<0.000001 
rs=0.8485 
p<0.000001 
Tumour longitudinal 
extent 
rs=0.378 
p=0.010393 
rs=0.3794 
p=0.010131 
Distance lesion-
puborectalis muscle 
rs=0.7954 
p<0.000001 
rs=0.7989 
p<0.000001 
Depth of extramural 
spread 
rs=0.5107 
p=0.000149 
rs=0.5046 
p=0.000186 
Levator ani muscles 
infiltration 
82% 80% 
Lymph node 
involvement 
68% 76% 
Pelvic organs infiltration 
 
80% 80% 
 
 
Table 4: Accuracy of ERUS examination to predict the 
correct T stage. 
  T1 T2 T3 T4 Tot HE 
T1 0 0 0 0 0  
T2 0 0 0 0 0  
T3 0 3 3 1 7  
T4 0 1 3 0 4  
Tot 0 4 6 1 11  
ERUS       
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Table 5: Accuracy of MRI examination to predict the correct 
T stage. 
  T1 T2 T3 T4 Tot HE 
T1 0 0 0 0 0  
T2 0 0 0 0 0  
T3 0 2 4 0 6  
T4 0 2 2 1 5  
Tot 0 4 6 1 11  
MRI       
 
 
Table 6: Comparison of overstaged and understaged cases by 
MRI and ERUS. 
 T stage N stage 
 Overstaged Understaged Overstaged Understaged 
ERUS 7 (63.6%) 1 (9.1%) 3 (27.3%) 1 (9.1%) 
MRI 6 (54.5%) 0 3 (27.3%) 1 (9.1%) 
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Fig.1: 3D ERUS image of the rectal wall layers. 
 
 
 
Fig.2: MR image of the rectal wall layers. 
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